IRONWOOD PHARMACEUTICALS INC Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Ironwood Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q3 2025.
  • Ironwood Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 178M shares, a 10.9% increase year-over-year.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 160M shares, a 2.99% increase from 2023.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 155M shares, a 16.6% decline from 2022.
  • Ironwood Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 186M shares, a 13.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

IRONWOOD PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 178M +17.5M +10.9% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 177M +17.8M +11.2% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 161M +3.27M +2.08% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 160M +4.65M +2.99% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 160M -26.7M -14.3% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 159M +3.65M +2.35% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 158M -29M -15.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 155M -30.9M -16.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 187M +2.43M +1.32% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 155M -29.5M -16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 187M -2.86M -1.51% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 186M +21.9M +13.3% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-31
Q3 2022 184M +19.2M +11.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 185M +21.4M +13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 190M +27.2M +16.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 164M +3.76M +2.34% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 165M +4.96M +3.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 163M +3.58M +2.24% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 162M +2.38M +1.49% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 161M +4.63M +2.97% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 160M +3.45M +2.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 160M +4.07M +2.61% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 160M +5.01M +3.24% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 156M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 157M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 156M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 155M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2013 121M +6.43M +5.63% Jul 1, 2013 Sep 30, 2013 10-Q 2013-10-28
Q3 2012 114M +14.2M +14.1% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 107M +7.4M +7.43% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 104M +4.68M +4.72% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-10
Q4 2011 99.9M Oct 1, 2011 Dec 31, 2011 10-K 2012-02-29
Q3 2011 100M +2.25M +2.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 99.7M +2.03M +2.08% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 99.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 97.9M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 97.6M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12

IRONWOOD PHARMACEUTICALS INC Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 160M +4.65M +2.99% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 155M -30.9M -16.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 186M +21.9M +13.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-31
2021 164M +3.76M +2.34% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 161M +4.63M +2.97% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-16
2019 156M +3.39M +2.22% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 153M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-17
2011 99.9M +10.2M +11.4% Jan 1, 2011 Dec 31, 2011 10-K 2012-02-29
2010 89.7M Jan 1, 2010 Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.